Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Celyad SA (CLYYF) vs. Competitors

9 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CLYYFCelyad SA$0.28$7.27M1.6940.00%―Unlock the CLYYF analyst price target with TipRanks PremiumCLYYFUnlock the CLYYF top-analyst price target with TipRanks Premium
NWBONorthwest Biotherapeutics$0.15$249.36M-6.17-38.91%―Unlock the NWBO analyst price target with TipRanks PremiumCLYYF vs NWBOUnlock the NWBO top-analyst price target with TipRanks Premium
SRNESorrento Therapeutics$0.00$165.38K0.00-94.05%―Unlock the SRNE analyst price target with TipRanks PremiumCLYYF vs SRNEUnlock the SRNE top-analyst price target with TipRanks Premium
BMRNBioMarin Pharmaceutical$57.99$11.23B-645.555.96%Moderate BuyUnlock the BMRN analyst price target with TipRanks PremiumCLYYF vs BMRNUnlock the BMRN top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CLYYFCelyad SA0.280.0840.00%
NWBONorthwest Biotherapeutics0.15-0.09-36.80%
SRNESorrento Therapeutics―――
BMRNBioMarin Pharmaceutical57.993.536.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts